Light To Guide Our Feet
Light To Guide Our Feet

Menu

Collapse

Search Result

Collapse

Announcement

Collapse
No announcement yet.

What's Going On

Collapse

There are currently 116 users online. 26 members and 90 guests.

Most users ever online was 3,930 at 07:07 PM on 04-20-2019.

170 results in 0.0096 seconds.
Keywords
Members
Tags
health x
  •  

  • NIH says Fourth Iteration of COVID-19 Treatment Trial underway

    NIH says Fourth Iteration of COVID-19 Treatment Trial underway

    National Institutes of Health says Fourth Iteration of COVID-19 Treatment Trial underway| site |


    (Information contained in National Institutes of Health [NIH] press release: November 25, 2020) The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, today announced that the fourth iteration of the Adaptive COVID-19 Treatment Trial (ACTT-4) has begun to enroll hospitalized adults with coronavirus disease 2019 (COVID-19) who require supplemental oxygen. The NIAID-sponsored trial will enroll up to 1,500 patients at approximately 100 sites in the United States and other countries. Participants will be assigned at random to one of two treatment arms of equal size. One group will receive both dexamethasone, a corticosteroid available as a generic drug, and remdesivir, a broad-spectrum antiviral discovered and developed by Gilead Sciences, Inc., of Foster City, California. Remdesivir, also known as Veklury, was r...
    See more | Go to post

  • Four Major Health Care Organizations release Updated Guidance on Maintaining Essential Surgery during the Ongoing Pandemic

    American Hospital Association says, As COVID-19 Cases surge again, four Major Health Care Organizations release Updated Guidance on Maintaining Essential Surgery during the Ongoing Pandemic | site |



    (Information contained in American Hospital Association press release: November 24, 2020)


    As COVID-19 cases surge again, four major health care organizations release updated guidance on maintaining essential surgery during the ongoing pandemic


    Joint roadmap addresses the dual need to meet health care demands for patients hospitalized with COVID-19, along with patients who need essential surgical services; calls for centralized coordinated governmental action to deploy necessary supplies


    CHICAGO (November 24, 2020): Hospitals in many regions across the United States are now reporting near or at bed and ICU capacity due to the resurgence of the Coronavirus Disease 2019 (COVID-19), which is presenting new...
    See more | Go to post

  • Statement from HHS Chief of Staff Brian Harrison on Efforts to Increase Transparency at HHS

    Statement from U.S. Department of Health and Human Services Chief of Staff Brian Harrison on Efforts to Increase Transparency at HHS | site |


    (Information contained in U.S. Department of Health and Human Services press release: November 24, 2020)

    Today, the Department of Health and Human Services (HHS) through a Notice published in the Federal Register announced a policy to enhance transparency at HHS by requiring that all assumptions, working papers, models, and other information used as part of any impact analysis associated with a rule or demonstration project are shared at the time the results of that analysis are publicly disclosed. HHS Chief of Staff Brian Harrison issued the following statement:

    “We are providing needed transparency by requiring the Department to show its math so the American people can know and challenge the methods government uses to calculate effects of regulations it imposes on them.”

    Frequently
    ...
    See more | Go to post

  • NIH says Commonly used Antibiotic shows Promise for Combating Zika Infections

    NIH says Commonly used Antibiotic shows Promise for Combating Zika Infections

    National Institutes of Health says Commonly used Antibiotic shows Promise for Combating Zika Infections | site |


    NIH preclinical study suggests FDA-approved tetracycline-based antibiotics may slow infection and reduce neurological problems.


    (Information contained in National Institutes of Health [NIH] press release: November 24, 2020)

    In 2015, hundreds of children were born with brain deformities resulting from a global outbreak of Zika virus infections. Recently, National Institutes of Health researchers used a variety of advanced drug screening techniques to test out more than 10,000 compounds in search of a cure. To their surprise, they found that the widely used antibiotic methacycline was effective at preventing brain infections and reducing neurological problems associated with the virus in mice. In addition, they found that drugs originally designed to combat Alzheimer’s disease and inflammation may also help fight infections. ...
    See more | Go to post

  • HHS and DOD Award 11.6 Million Dollars Contract to Puritan Medical Products to Boost U.S. Production of Swabs for Cue Health COVID-19 Tests

    HHS and DOD Award $11.6 Million Contract to Puritan Medical Products to Boost U.S. Production of Swabs for Cue Health COVID-19 Tests | site |


    (Information contained in U.S. Department of Health and Human Services press release: November 23, 2020) The U.S. Department of Health and Human Services (HHS) and the U.S. Department of Defense (DOD) have jointly awarded an $11.6 million contract to Puritan Medical Products Company, LLC, to expand domestic production capacity of Cue Sample Wands, the nasal swabs used exclusively with the COVID-19 cartridge-based molecular testing system developed and manufactured by Cue Health, Inc. The test generates results in about 20 minutes at the point-of-care (POC). Awarded November 19, the new contract will allow Puritan Medical to expedite upgrades at its Maine facility and increase production capability of Cue’s nasal swabs to 3 million per month by March 2021. These efforts support the federal government’s procurement of 6 millio...
    See more | Go to post

  • AMA CEO says COVID-19 is a Painful Validation of Our Long-term Vision for Health Care

    American Medical Association CEO says "COVID-19 is a Painful Validation of Our Long-term Vision for Health Care" | site |





    (Information contained in American Medical Association [AMA] press release: November 13, 2020)





    AMA CEO James L. Madara, MD



    In his address to the House of Delegates at the American Medical Association (AMA) November Special Meeting, AMA CEO James L. Madara, MD, highlights how the AMA has supported physicians during the pandemic and how COVID-19 is a painful validation of the organization’s long-term strategic vision for health care.






    ...
    See more | Go to post

  • Decades of National Institutes of Health Research help lead to first FDA-approved Treatment for Progeria

    Decades of National Institutes of Health Research help lead to first FDA-approved Treatment for Progeria | site |


    (Information included in a National Institutes of Health [NIH] news release media advisory: November 23, 2020)

    The U.S. Food and Drug Administration has approved the first treatment for progeria, a rare and fatal pediatric disease, characterized by dramatic, rapid aging beginning in childhood. The treatment was made possible thanks in part to work at the National Institutes of Health over nearly two decades to identify and understand the function of the mutant gene and the protein it encodes (called progerin), with the goal of identifying new therapeutic drugs for the disorder. Progeria, also known as Hutchinson-Gilford progeria syndrome, is a rare, multisystemic disease that causes premature aging and premature death in children. Progeria is caused by a genetic mutation in the LMNA (“lamin A”) gene, which helps maintain the normal
    ...
    See more | Go to post

  • CDC issues revised COVID-19 Travel Health Notice Levels and Testing for International Travelers

    Centers for Disease Control and Prevention issues revised COVID-19 Travel Health Notice Levels and Testing for International Travelers| site |


    (Information contained in Centers for Disease Control and Prevention (CDC) press release: November 22, 2020)

    On Saturday, November 21, CDC revised the Travel Health Notice system for COVID-19 and released new recommendations for testing before and after international air travel to help the public make informed decisions for safer, healthier, and more responsible travel during the COVID-19 pandemic.

    CDC’s Travel Health Notices inform travelers and clinicians about current health issues in destinations around the world. For most diseases, the Travel Health Notices have 3 levels. This new 4-level travel health notice system is specific to COVID-19 and details the level of COVID-19 in international destinations and U.S. territories. The COVID-19 Travel Health Notices now indicate low, moderate, high, and
    ...
    See more | Go to post

  • HHS Launches Pilot Program of Fast Molecular POC Test for COVID-19

    HHS Launches Pilot Program of Fast Molecular POC Test for COVID-19

    U.S. Department of Health and Human Services Launches Pilot Program of Fast Molecular POC Test for COVID-19 | site |


    HHS says Alaska, Florida, Louisiana, New Jersey, and Texas Receive First Shipments of Test Used in NBA Bubble


    (Information contained in HHS press release: November 19, 2020) The U.S. Department of Health and Human Services (HHS) has launched a pilot program with five states to use portable, cartridge-based COVID-19 molecular test kits that provide rapid results. The pilot program will assess how to best integrate diagnostic technology developed by Cue Health, Inc., into strategies for disease surveillance and infection control in institutions such as nursing homes. Used successfully as the primary molecular point-of-care (POC) test to control the spread of COVID-19 within in the National Basketball Association “bubble,” as well as by leading healthcare providers in the U.S., the nasal swab POC test generates results in ab...
    See more | Go to post

  • CDC Expands U.S. Diabetes Surveillance System with new Social Determinants of Health Module

    CDC Expands U.S. Diabetes Surveillance System with new Social Determinants of Health Module | site |


    New tool identifies Diabetes-Related Health Disparities


    (Information contained in CDC press release: November 17, 2020)

    The Centers for Disease and Control and Prevention (CDC) has expanded the U.S. Diabetes Surveillance System with a new social determinants of health (SDOH) module to help identify under-resourced areas of the United States and assess the potential impact of health disparities on diabetes burden and risk factors.

    The expanded U.S. Diabetes Surveillance System now overlays diabetes data with 15 social vulnerability variables. The SDOH module gives public health professionals and researchers a more complete look at factors potentially impacting people’s ability to successfully manage diabetes and prevent type 2 diabetes around the U.S. Data are available at the national level to compare counties across stat
    ...
    See more | Go to post

  • U.S. Department of Labor's OSHA announces 2,856,533 Dollars in Coronavirus Violations

    U.S. Department of Labor's OSHA announces $2,856,533 in Coronavirus Violations | site |


    (November 13, 2020) - - On November 13, 2020 the U.S. Department of Labor published information that included the following:

    WASHINGTON, DC – Since the start of the coronavirus pandemic through Nov. 5, 2020, the U.S. Department of Labor’s Occupational Safety and Health Administration (OSHA) has issued 204 citations arising from inspections for violations relating to coronavirus, resulting in proposed penalties totaling $2,856,533.

    OSHA inspections have resulted in the agency citing employers for violations, including failures to:
    • Provide a medical evaluation, respirator fit test, training on the proper use of a respirator and personal protective equipment;
    ...
    See more | Go to post

  • CMS publishes Medicaid and Children’s Health Insurance Program Managed Care Final Rule Fact Sheet

    Centers for Medicare and Medicaid Services publishes Medicaid and Children’s Health Insurance Program Managed Care Final Rule Fact Sheet | site |



    (November 9, 2020) - - On November 9, 2020 the Centers for Medicare and Medicaid Services (CMS) published the following:


    Medicaid & Children’s Health Insurance Program (CHIP) Managed Care Final Rule - CMS-2408-F

    Overview The announcement of the 2020 Medicaid & CHIP Managed Care final rule highlights the Trump Administration’s continued commitment to reduce administrative burden and cut red tape, support state flexibility, and promote transparency and innovation in the Medicaid and CHIP programs for the growing number of people in Medicaid and CHIP managed care. This final rule finalizes policies from the Notice of Proposed Rule Making issued in November 2018. Based on 2018 state Medicaid and CHIP enrollment data, eighty three percent, or around 66 million people, are enrolled in...
    See more | Go to post

  • U.S. Department of Veterans Affairs confirms Authority for its Health Care Professionals to Practice across State Lines

    U.S. Department of Veterans Affairs confirms Authority for its Health Care Professionals to Practice across State Lines | site |


    (November 13, 2020) - - Today, November 13, 2020, the U.S. Department of Veterans Affairs published the following information:

    WASHINGTON — The U.S. Department of Veterans Affairs (VA) announced today it published an interim final rule affirming VA’s current policy allowing VA health care professionals to practice across state lines in accordance with the scope and requirements of their VA employment, regardless of conflicting state requirements.

    This regulation allows VA the flexibility to mobilize and hire qualified health care professionals from any state and quickly place them in areas of need — which is especially important during the COVID-19 pandemic.

    VA maintains and continues to exercise this authority. Reaching beyond the coronavirus pandemic and as identified in “VA’s Fourth Mission”,
    ...
    See more | Go to post

  • National Institutes of Health says Cardiac Arrest Treatment that uses Life Support Machine boosts Survival

    National Institutes of Health says Cardiac Arrest Treatment that uses Life Support Machine boosts Survival | site |


    (November 13, 2020) - - Today the National Institutes of Health (NIH) published the following information:

    Using a life support machine to replicate the functions of the heart and lungs significantly improved the survival of people who suffered from out-of-hospital cardiac arrest, according to a new study published today in The Lancet . The treatment program involving the life support machine called extracorporeal membrane oxygenation (ECMO) proved so much more effective than the standard treatment for this usually fatal condition that the trial was stopped early after enrolling just 30 of the expected 165 patients. The study, known as the Advanced Reperfusion Strategies for Refractory Cardiac Arrest (ARREST) trial, was funded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health. It found th
    ...
    See more | Go to post

  • HHS allocates Lilly therapeutic to treat Patients with Mild to Moderate COVID-19

    HHS allocates Lilly therapeutic to treat Patients with Mild to Moderate COVID-19

    U.S. Department of Health and Human Services allocates Lilly therapeutic to treat Patients with Mild to Moderate COVID-19 | site |




    (November 10, 2020) - - Today the U.S. Department of Health and Human Services (HHS) published the following information:

    The U.S. Department of Health and Human Services today announced plans to allocate initial doses of Eli Lilly and Company’s investigational monoclonal antibody therapeutic, bamlanivimab, which received emergency use authorization from the U.S. Food and Drug Administration November 9 for the treatment of non-hospitalized patients with mild or moderate confirmed cases of COVID-19.

    On October 28, the federal government announced a purchase of 300,000 doses of bamlanivimab. HHS will allocate these doses to state and territorial health departments which, in turn, will determine which healthcare facilities receive the infusion drug. The federal government can purchase up to 650,000 additional
    ...
    See more | Go to post

Menu

Collapse

Trending

Collapse

  • Staff Reporter 1
    NIH says Fourth Iteration of COVID-19 Treatment Trial underway
    by Staff Reporter 1
    National Institutes of Health says Fourth Iteration of COVID-19 Treatment Trial underway| site |


    (Information contained in National Institutes of Health [NIH] press release: November 25, 2020) The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, today announced that the fourth iteration of the Adaptive COVID-19 Treatment Trial (ACTT-4) has begun to enroll hospitalized adults with coronavirus disease 2019 (COVID-19) who require supplemental oxygen. The NIAID-sponsored trial will enroll up to 1,500 patients at approximately 100 sites in the United States and other countries. Participants will be assigned at random to one of two treatment arms of equal size. One group will receive both dexamethasone, a corticosteroid available as a generic drug, and remdesivir, a broad-spectrum antiviral discovered and developed by Gilead Sciences, Inc., of Foster City, California. Remdesivir, also known as Veklury, was r...
    11-26-2020, 04:28 AM
  • Staff Reporter 1
    Four Major Health Care Organizations release Updated Guidance on Maintaining Essential Surgery during the Ongoing Pandemic
    by Staff Reporter 1
    American Hospital Association says, As COVID-19 Cases surge again, four Major Health Care Organizations release Updated Guidance on Maintaining Essential Surgery during the Ongoing Pandemic | site |



    (Information contained in American Hospital Association press release: November 24, 2020)


    As COVID-19 cases surge again, four major health care organizations release updated guidance on maintaining essential surgery during the ongoing pandemic


    Joint roadmap addresses the dual need to meet health care demands for patients hospitalized with COVID-19, along with patients who need essential surgical services; calls for centralized coordinated governmental action to deploy necessary supplies


    CHICAGO (November 24, 2020): Hospitals in many regions across the United States are now reporting near or at bed and ICU capacity due to the resurgence of the Coronavirus Disease 2019 (COVID-19), which is presenting new...
    11-25-2020, 08:26 AM
  • Staff Reporter 1
    Statement from HHS Chief of Staff Brian Harrison on Efforts to Increase Transparency at HHS
    by Staff Reporter 1
    Statement from U.S. Department of Health and Human Services Chief of Staff Brian Harrison on Efforts to Increase Transparency at HHS | site |


    (Information contained in U.S. Department of Health and Human Services press release: November 24, 2020)

    Today, the Department of Health and Human Services (HHS) through a Notice published in the Federal Register announced a policy to enhance transparency at HHS by requiring that all assumptions, working papers, models, and other information used as part of any impact analysis associated with a rule or demonstration project are shared at the time the results of that analysis are publicly disclosed. HHS Chief of Staff Brian Harrison issued the following statement:

    “We are providing needed transparency by requiring the Department to show its math so the American people can know and challenge the methods government uses to calculate effects of regulations it imposes on them.”

    Frequently
    ...
    11-24-2020, 09:24 PM
  • Staff Reporter 1
    NIH says Commonly used Antibiotic shows Promise for Combating Zika Infections
    by Staff Reporter 1
    National Institutes of Health says Commonly used Antibiotic shows Promise for Combating Zika Infections | site |


    NIH preclinical study suggests FDA-approved tetracycline-based antibiotics may slow infection and reduce neurological problems.


    (Information contained in National Institutes of Health [NIH] press release: November 24, 2020)

    In 2015, hundreds of children were born with brain deformities resulting from a global outbreak of Zika virus infections. Recently, National Institutes of Health researchers used a variety of advanced drug screening techniques to test out more than 10,000 compounds in search of a cure. To their surprise, they found that the widely used antibiotic methacycline was effective at preventing brain infections and reducing neurological problems associated with the virus in mice. In addition, they found that drugs originally designed to combat Alzheimer’s disease and inflammation may also help fight infections. ...
    11-24-2020, 08:57 PM
  • Staff Reporter 1
    HHS and DOD Award 11.6 Million Dollars Contract to Puritan Medical Products to Boost U.S. Production of Swabs for Cue Health COVID-19 Tests
    by Staff Reporter 1
    HHS and DOD Award $11.6 Million Contract to Puritan Medical Products to Boost U.S. Production of Swabs for Cue Health COVID-19 Tests | site |


    (Information contained in U.S. Department of Health and Human Services press release: November 23, 2020) The U.S. Department of Health and Human Services (HHS) and the U.S. Department of Defense (DOD) have jointly awarded an $11.6 million contract to Puritan Medical Products Company, LLC, to expand domestic production capacity of Cue Sample Wands, the nasal swabs used exclusively with the COVID-19 cartridge-based molecular testing system developed and manufactured by Cue Health, Inc. The test generates results in about 20 minutes at the point-of-care (POC). Awarded November 19, the new contract will allow Puritan Medical to expedite upgrades at its Maine facility and increase production capability of Cue’s nasal swabs to 3 million per month by March 2021. These efforts support the federal government’s procurement of 6 millio...
    11-24-2020, 06:31 AM

Menu

Collapse

Menu

Collapse

Working...
X